DESMOID TUMOR
Clinical trials for DESMOID TUMOR explained in plain language.
Never miss a new study
Get alerted when new DESMOID TUMOR trials appear
Sign up with your email to follow new studies for DESMOID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare tumor patients: drug targets desmoid growth
Disease control OngoingThis study tests a drug called nirogacestat in 20 Japanese adults with desmoid tumors that are growing. Desmoid tumors are non-cancerous but can cause pain and disability. The goal is to see if the drug can shrink or stop the tumors. Participants take the drug by mouth and are mo…
Matched conditions: DESMOID TUMOR
Phase: PHASE2 • Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 17, 2026 04:12 UTC
-
New hope for rare tumor patients: AL102 drug trial shows promise
Disease control OngoingThis study tests a drug called AL102 in adults with desmoid tumors that are getting worse. Desmoid tumors are non-cancerous growths that can cause pain and other problems. The goal is to see if AL102 can stop the tumors from growing or shrink them. About 198 people will take part…
Matched conditions: DESMOID TUMOR
Phase: PHASE2, PHASE3 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated Apr 24, 2026 16:06 UTC
-
Massive italian study tracks rare gut condition to improve care
Knowledge-focused OngoingThis study gathers information from 1500 people with inherited conditions that cause many colon polyps and raise cancer risk. Researchers will track how the disease develops, what treatments people receive, and their long-term health. The goal is to create better guidelines and r…
Matched conditions: DESMOID TUMOR
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC